Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 91.84
0.207 %
$ 114 B
Market Cap
20.73
P/E
GILD - REVENUE
Revenue GILD - Gilead Sciences, Inc.
27.1 B
LAST VALUE
-0.35%
2 YEAR CAGR
4.15%
5 YEAR CAGR
9.24%
10 YEAR CAGR